Enhancement of siRNA transfection by the optimization of fatty acid length and histidine content in the CPP.

Extracellular synthetic nucleic acids, such as siRNAs, are unable to reach their intended targets efficiently. Therefore, delivery methods such as cell-penetrating peptides (CPP), which increase their transport, could enhance the potency of siRNA as therapeutic agents. The CPP NickFect55 (NF55) is an efficient peptide-based delivery vector, which has been previously used to deliver plasmid DNA into cells in vivo. To achieve higher intracellular delivery and bioactivity from the delivered cargo, we designed a series of histidine-containing peptides by optimizing pH-sensitivity, net charge, hydrophobicity, and charge distribution in the sequence of the CPP NF55. In the current work, we have applied a strategy where we have replaced amino acids in the C-terminus of the peptide in order to distribute hydrophobic and hydrophilic amino acids into distinct regions along the alpha-helical projection, including histidine amino acids into the sequence at the N-terminus, and optimizing the N-terminal fatty acid modification to suit the specific peptide sequence. We tested the CPPs based on the transfection efficacy, CPP/siRNA complex stability, and the properties of the CPPs, such as hemolytic activity, buffering capability and cell toxicity. As a result, we have introduced a new peptide with a completely redesigned N-terminus that displays adaptive response to its physical environment. This peptide - NickFect70 (NF70) - efficiently condenses siRNA, protects the cargo against degradation and effectively mediates target gene knockdown both in mammalian cell culture and in vivo, in a mouse model.

[1]  Li Li,et al.  Design of a new pH‐activatable cell‐penetrating peptide for drug delivery into tumor cells , 2019, Chemical biology & drug design.

[2]  I. V. Chernikov,et al.  Current Development of siRNA Bioconjugates: From Research to the Clinic , 2019, Front. Pharmacol..

[3]  A. Mason,et al.  Histidine‐rich designer peptides of the LAH4 family promote cell delivery of a multitude of cargo , 2017, Journal of peptide science : an official publication of the European Peptide Society.

[4]  M. Pooga,et al.  Saturated Fatty Acid Analogues of Cell-Penetrating Peptide PepFect14: Role of Fatty Acid Modification in Complexation and Delivery of Splice-Correcting Oligonucleotides. , 2017, Bioconjugate chemistry.

[5]  T. Tenson,et al.  The Formation of Nanoparticles between Small Interfering RNA and Amphipathic Cell-Penetrating Peptides , 2017, Molecular therapy. Nucleic acids.

[6]  Zhao Meng,et al.  Histidine-enriched multifunctional peptide vectors with enhanced cellular uptake and endosomal escape for gene delivery. , 2017, Journal of materials chemistry. B.

[7]  Takashi Iwasaki,et al.  Short polyhistidine peptides penetrate effectively into Nicotiana tabacum-cultured cells and Saccharomyces cerevisiae cells , 2017, Bioscience, biotechnology, and biochemistry.

[8]  M. Pooga,et al.  Optimization of in vivo DNA delivery with NickFect peptide vectors. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[9]  Sourav Bhattacharjee,et al.  DLS and zeta potential - What they are and what they are not? , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[10]  M. Hällbrink,et al.  pH-responsive PepFect cell-penetrating peptides. , 2016, International journal of pharmaceutics.

[11]  M. Pooga,et al.  Characteristics of Cell-Penetrating Peptide/Nucleic Acid Nanoparticles. , 2016, Molecular pharmaceutics.

[12]  J. DeSimone,et al.  Reductively Responsive Hydrogel Nanoparticles with Uniform Size, Shape, and Tunable Composition for Systemic siRNA Delivery in Vivo. , 2015, Molecular pharmaceutics.

[13]  Pu Chen,et al.  Effective small interfering RNA delivery in vitro via a new stearylated cationic peptide , 2015, International journal of nanomedicine.

[14]  Yong Ren,et al.  Recent advances in nanoparticle-mediated siRNA delivery. , 2014, Annual review of biomedical engineering.

[15]  M. Castanho,et al.  Cell‐penetrating peptides: A tool for effective delivery in gene‐targeted therapies , 2014, IUBMB life.

[16]  G. Nienhaus,et al.  Engineered nanoparticles interacting with cells: size matters , 2014, Journal of Nanobiotechnology.

[17]  Jie Tang,et al.  A pH-responsive α-helical cell penetrating peptide-mediated liposomal delivery system. , 2013, Biomaterials.

[18]  Ű. Langel,et al.  Differential endosomal pathways for radically modified peptide vectors. , 2013, Bioconjugate chemistry.

[19]  Yasumasa Kato,et al.  Acidic extracellular microenvironment and cancer , 2013, Cancer Cell International.

[20]  I. Nabi,et al.  Influence of cationic lipid composition on uptake and intracellular processing of lipid nanoparticle formulations of siRNA. , 2013, Nanomedicine : nanotechnology, biology, and medicine.

[21]  Baoling Chen,et al.  A new amphipathic, amino-acid-pairing (AAP) peptide as siRNA delivery carrier: physicochemical characterization and in vitro uptake. , 2012, The journal of physical chemistry. B.

[22]  Justin H Lo,et al.  Identification and Characterization of Receptor-Specific Peptides for siRNA Delivery , 2012, ACS nano.

[23]  Ernst Wagner,et al.  Therapeutic plasmid DNA versus siRNA delivery: common and different tasks for synthetic carriers. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[24]  D. Scherman,et al.  Control of pH responsive peptide self-association during endocytosis is required for effective gene transfer. , 2012, Biochimica et biophysica acta.

[25]  M. Pooga,et al.  Cell-penetrating peptides as versatile vehicles for oligonucleotide delivery. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

[26]  E. Vázquez,et al.  Biological activities of histidine-rich peptides; merging biotechnology and nanomedicine , 2011, Microbial cell factories.

[27]  Kairong Wang,et al.  Design of acid-activated cell penetrating peptide for delivery of active molecules into cancer cells. , 2011, Bioconjugate chemistry.

[28]  L. Gentilucci,et al.  Chemical modifications designed to improve peptide stability: incorporation of non-natural amino acids, pseudo-peptide bonds, and cyclization. , 2010, Current pharmaceutical design.

[29]  R. Brasseur,et al.  A new potent secondary amphipathic cell-penetrating peptide for siRNA delivery into mammalian cells. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[30]  M. Morris,et al.  Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy. , 2008, Advanced drug delivery reviews.

[31]  Zheng-Rong Lu,et al.  Novel polymerizable surfactants with pH-sensitive amphiphilicity and cell membrane disruption for efficient siRNA delivery. , 2007, Bioconjugate chemistry.

[32]  A. Kichler,et al.  Self-promoted cellular uptake of peptide/DNA transfection complexes. , 2007, Biochemistry.

[33]  Simon W. Jones,et al.  Lung delivery studies using siRNA conjugated to TAT(48-60) and penetratin reveal peptide induced reduction in gene expression and induction of innate immunity. , 2007, Bioconjugate chemistry.

[34]  Phillip D. Zamore,et al.  RNA silencing: Genomic defence with a slice of pi , 2007, Nature.

[35]  A. J. Mixson,et al.  Highly branched HK peptides are effective carriers of siRNA , 2005, The journal of gene medicine.

[36]  J. Strominger,et al.  A pH-sensitive histidine residue as control element for ligand release from HLA-DR molecules , 2002, Proceedings of the National Academy of Sciences of the United States of America.